Cancer survivorship: A pediatric perspective

Oncologist

Volumn 13, Issue 11, 2008, Pages 1181-1192

  Landier, Wendy ^a   Bhatia, Smita ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Childhood cancer survivors; Evaluation for late effects; Late effects; Long term follow up guidelines

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GROWTH HORMONE; LOMUSTINE; METHOTREXATE; METHYLPHENIDATE; TENIPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT RESPIRATORY DISTRESS SYNDROME; AMENORRHEA; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOPULMONARY INSUFFICIENCY; CHILDHOOD CANCER; COGNITIVE DEFECT; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; EARLY MENOPAUSE; ENDOCRINE DISEASE; FOLLOW UP; GONAD DYSFUNCTION; GONAD FUNCTION; GROWTH RETARDATION; HEALTH CARE UTILIZATION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; INFERTILITY; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; LUNG FIBROSIS; MALE INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MORBIDITY; MUSCULOSKELETAL DISEASE; MYELODYSPLASIA; NEUROLOGIC DISEASE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA; REVIEW; SCREENING; SURVIVAL RATE; TREATMENT OUTCOME;

ANTHRACYCLINES; COGNITION; FEMALE; FOLLOW-UP STUDIES; GONADS; HEART; HUMANS; LUNG; MALE; MORBIDITY; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; SURVIVORS; YOUNG ADULT;

EID: 56749161747     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0104     Document Type: Review

References (64)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Hewitt M, Weiner SL, Simone JVE. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academies Press, 2003:1-14.
3. Oeffinger KC, Mertens AC, Sklar CA et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
4. Stevens MC, Mahler H, Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer 1998;34:694-698.
5. Garre ML, Gandus S, Cesana B et al. Health status of long-term survivors after cancer in childhood. Results of an uniinstitutional study in Italy. Am J Pediatr Hematol Oncol 1994;16:143-152.
6. Oeffinger KC, Eshelman DA, Tomlinson GE et al. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000;88:1687-1695.
7. Kadan-Lottick NS, Robison LL, Gurney JG et al. Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA 2002;287:1832-1839.
8. Landier W, Bhatia S, Eshelman DA et al. Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004;22:4979-4990.
9. Inskip PD, Ries LAG, Cohen RJ et al. New malignancies following childhood cancer. In: Curtis RE, Freedman DM, Ron E, et al., eds. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. NIH Publication No. 05-5302. Bethesda, MD: National Cancer Institute, 2006:465-482.
10. Bhatia S, Robison LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751.
11. Bhatia S, Yasui Y, Robison LL et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group. J Clin Oncol 2003;21:4386-4394.
12. Neglia JP, Friedman DL, Yasui Y et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-629.
13. Wong FL, Boice JD Jr, Abramson DH et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278:1262-1267.
14. Hawkins MM, Wilson LM, Burton HS et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996;88:270-278.
15. Sigurdson AJ, Ronckers CM, Mertens AC et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 2005;365:2014-2023.
16. Neglia JP, Robison LL, StovallMet al. New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:1528-1537.
17. de Vathaire F, Hawkins M, Campbell S et al. Second malignant neoplasms after a first cancer in childhood: Temporal pattern of risk according to type of treatment. Br J Cancer 1999;79:1884-1893.
18. Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 2002;100:1989-1996.
19. Diller L, Medeiros Nancarrow C, ShafferKet al. Breast cancer screening in women previously treated for Hodgkin's disease: A prospective cohort study. J Clin Oncol 2002;20:2085-2091.
20. Saslow D, Boetes C, Burke W et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
21. Lorigan P, Radford J, Howell A et al. Lung cancer after treatment for Hodgkin's lymphoma: A systematic review. Lancet Oncol 2005;6:773-779.
22. Fletcher O, Easton D, Anderson K et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96:357-363.
23. Kleinerman RA, Tucker MA, Tarone RE et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 2005;23:2272-2279.
24. Hisada M, Garber JE, Fung CY et al. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-611.
25. Moore BD 3rd. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 2005;30:51-63.
26. Mulhern RK, Merchant TE, Gajjar A et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5:399-408.
27. Mulhern RK, Reddick WE, Palmer SL et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999;46:834-841.
28. Mitby PA, Robison LL, Whitton JA et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 2003;97:1115-1126.
29. Mulhern RK, Khan RB, Kaplan S et al. Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004;22:4795-4803.
30. Nathan PC, Patel SK, Dilley K et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: A report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007;161:798-806.
31. Grenier MA, Lipshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 1998;25(suppl 10):72-85.
32. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 2008;94:525-533.
33. Pein F, Sakiroglu O, Dahan M et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer 2004;91:37-44.
34. Fajardo LF, Stewart JR, Cohn KE. Morphology of radiation-induced heart disease. Arch Pathol 1968;86:512-519.
35. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999;51:35-42.
36. Adams MJ, Hardenbergh PH, Constine LS et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003;45:55-75.
37. Shankar SM, Marina N, Hudson MM et. al. Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 2008;121:e387-e396.
38. Griese M, Rampf U, Hofmann D et al. Pulmonary complications after bone marrow transplantation in children: Twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000;30:393-401.
39. Eigen H, Wyszomierski D. Bleomycin lung injury in children: Pathophysiology and guidelines for management. Am J Pediatr Hematol Oncol 1985;7:71-78.
40. Schwerzmann M, Seiler C. Recreational scuba diving, patent foramen ovale and their associated risks. Swiss Med Wkly 2001;131:365-374.
41. Noorda EM, Somers R, van Leeuwen FE et al. Dutch Late Effects Study Group. Adult height and age at menarche in childhood cancer survivors. Eur J Cancer 2001;37:605-612.
42. Robison LL, Nesbit ME, Jr., Sather HN, Meadows AT, Ortega JA, Hammond GD. Height of children successfully treated for acute lymphoblastic leukemia: A report from the Late Effects Study Committee of Childrens Cancer Study Group. Med Pediatr Oncol 1985;13:14-21.
43. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2-8.
44. Sherins RJ, Olweny CLM, Ziegler JL. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med 1978;299:12-16.
45. Stillman RJ, Schinfeld JS, Schiff I et al. Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 1981;139:62-66.
46. Ortin TTS, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 1990;19:873-880.
47. Liesner RJ, Leiper AD, Hann IM et al. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994;12:916-924.
48. Matsumoto M, Shinohara O, Ishiguro H et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999;80:452-454.
49. Couto-Silva AC, Trivin C, Thibaud E et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28:67-75.
50. Sanders JE, Buckner CD, Leonard JM et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983;36:252-255.
51. Sklar CA, Mertens AC, Mitby P et al. Premature menopause in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:890-896.
52. Sklar C, Whitton J, Mertens A et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-3232.
53. Ness KK, Oakes JM, Punyko JA et al. Prevalence of the metabolic syndrome in relation to self-reported cancer history. Ann Epidemiol 2005;15:202-206.
54. Link K, Moell C, Garwicz S et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 2004;89:5003-5012.
55. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
56. Gurney JG, Ness KK, Sibley SD et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006;107:1303-1312.
57. Oeffinger KC, Mertens AC, Hudson MM et al. Health care of young adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Fam Med 2004;2:61-70.
58. Oeffinger KC. Longitudinal risk-based health care for adult survivors of childhood cancer. Curr Probl Cancer 2003;27:143-167.
59. Oeffinger KC. Childhood cancer survivors and primary care physicians. J Fam Pract 2000;49:689-690.
60. Rosen DS, Blum RW, Britto M et al. Transition to adult health care for adolescents and young adults with chronic conditions: Position paper of the Society for Adolescent Medicine. J Adolesc Health 2003;33:309-311.
61. Michaud PA, Suris JC, Viner R. The adolescent with a chronic condition. Part II: Healthcare provision. Arch Dis Child 2004;89:943-949.
62. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: Future directions for clinical care and research. Pediatr Blood Cancer 2006;46:143-148.
63. Ginsberg JP, Hobbie WL, Carlson CA et al. Delivering long-term follow-up care to pediatric cancer survivors: Transitional care issues. Pediatr Blood Cancer 2006;46:169-173.
64. Oeffinger KC, Wallace WH. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer 2006;46:135-142.